Health Daily American Samoa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Daily American Samoa.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on January 26, 2026

Jan. 26, 2026

BlueOcean Global Announces FDA 510(k) Clearance of the Excelsior™ External Fixation System

GlobeNewswire

Jan. 26, 2026

Muscular Dystrophy Association Marks Rare Disease Day by Spotlighting Community Stories Driving Progress in Research, Care, and Advocacy

GlobeNewswire

Jan. 26, 2026

New Clinical Data Demonstrate that VIVUS’ QSYMIA® in Combination with Digitally Enhanced Lifestyle Interventions (DELI) Leads to Significantly Greater Reductions in Weight and Cardiovascular Risk Compared with DELI Alone in Adults with Obesity

GlobeNewswire

Jan. 26, 2026

Truveta deepens oncology and scientific leadership with appointment of Johnathan Lancaster, MD, PhD as President and Chief Scientific Officer

GlobeNewswire

Jan. 26, 2026

Akari Therapeutics Files Key Patent and Unveils Second ADC Program AKTX-102 Targeting CEACAM5 Expressing Solid Tumors

GlobeNewswire

Jan. 26, 2026

GRI Bio Secures New U.S. Composition of Matter Patent Covering Novel Compound Structures

GlobeNewswire

Jan. 26, 2026

Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza

GlobeNewswire

Jan. 26, 2026

SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization

GlobeNewswire

Jan. 26, 2026

LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program

GlobeNewswire

Jan. 26, 2026

Arcutis Biotherapeutics, Inc. Announces Termination of Promotion Agreement with Kowa

GlobeNewswire

Jan. 26, 2026

Leios Therapeutics and BNC Korea Announce Strategic Collaboration to Accelerate Development of 10XB-101 in South Korea

GlobeNewswire

Jan. 26, 2026

A Study on Aging Unlocks Holy Grail of Sports Performance

GlobeNewswire

Jan. 26, 2026

Cogent Biosciences Announces Breakthrough Therapy Designation for Bezuclastinib in Combination with Sunitinib for Patients with Gastrointestinal Stromal Tumors (GIST)

GlobeNewswire

Jan. 26, 2026

Milestone Pharmaceuticals Announces U.S. Availability of CARDAMYST™ (etripamil) Nasal Spray, the First and Only FDA-Approved Self-Administered Treatment for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

GlobeNewswire

Jan. 26, 2026

Primmune Therapeutics Announces Additional Close of Series B Financing

GlobeNewswire

Jan. 26, 2026

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange

GlobeNewswire

Jan. 26, 2026

Invention of DNA "Page Numbers" Opens Up Vast Possibilities for the Bioeconomy

GlobeNewswire

Jan. 26, 2026

QHSLab (OTCQB:USAQ) Reports Preliminary Unaudited 2025 Financial Results With Strong Revenue Growth, Expanding Margins, and Significant Debt Reduction

GlobeNewswire

Jan. 26, 2026

Genyro Signs Exclusive License for “Sidewinder,” a Breakthrough DNA Construction Technology Featured in Nature

GlobeNewswire

Jan. 26, 2026

Joint Commission and NQF Aligning Serious Reportable Events and Sentinel Events Lists

GlobeNewswire